- Home
- ICAD vs XLO Comparison
ICAD vs XLO Comparison
Compare ICAD & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- XLO
- Stock Information
- Founded
- ICAD 1984
- XLO 2016
- Country
- ICAD United States
- XLO United States
- Employees
- ICAD N/A
- XLO N/A
- Industry
- ICAD Medical/Dental Instruments
- XLO Biotechnology: Pharmaceutical Preparations
- Sector
- ICAD Health Care
- XLO Health Care
- Exchange
- ICAD Nasdaq
- XLO Nasdaq
- Market Cap
- ICAD 40.8M
- XLO 43.5M
- IPO Year
- ICAD 1986
- XLO 2021
- Fundamental
- Price
- ICAD $1.64
- XLO $1.04
- Analyst Decision
- ICAD
- XLO Buy
- Analyst Count
- ICAD 0
- XLO 1
- Target Price
- ICAD N/A
- XLO $4.00
- AVG Volume (30 Days)
- ICAD 257.0K
- XLO 473.8K
- Earning Date
- ICAD 11-13-2024
- XLO 11-07-2024
- Dividend Yield
- ICAD N/A
- XLO N/A
- EPS Growth
- ICAD N/A
- XLO N/A
- EPS
- ICAD N/A
- XLO N/A
- Revenue
- ICAD $18,940,000.00
- XLO $4,620,000.00
- Revenue This Year
- ICAD $13.15
- XLO N/A
- Revenue Next Year
- ICAD $24.28
- XLO $428.64
- P/E Ratio
- ICAD N/A
- XLO N/A
- Revenue Growth
- ICAD 10.03
- XLO N/A
- 52 Week Low
- ICAD $1.18
- XLO $0.49
- 52 Week High
- ICAD $2.65
- XLO $1.93
- Technical
- Relative Strength Index (RSI)
- ICAD 42.66
- XLO 50.77
- Support Level
- ICAD $1.72
- XLO $0.90
- Resistance Level
- ICAD $2.05
- XLO $1.15
- Average True Range (ATR)
- ICAD 0.15
- XLO 0.18
- MACD
- ICAD -0.02
- XLO -0.03
- Stochastic Oscillator
- ICAD 0.00
- XLO 31.51
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).